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Abstract
Epidemiological studies demonstrate that the link between impaired fetal development
and glucose intolerance in later life is exacerbated by postnatal catch-up growth. Maternal
protein restriction (MPR) during pregnancy and lactation in the rat has been previously
demonstrated to lead to impaired glucose tolerance in adulthood, however the effects of
protein restoration during weaning on glucose homeostasis are largely unknown. Recent
in vitro studies have identified that the liver X receptor a (LXRa) maintains glucose
homeostasis by inhibiting critical genes involved in gluconeogenesis including G6pase (G6pc),
11b-Hsd1 (Hsd11b1) and Pepck (Pck1). Therefore, we hypothesized that MPR with postnatal
catch-up growth would impair LXRa in vivo, which in turn would lead to augmented
gluconeogenic LXRa-target gene expression and glucose intolerance. To examine this
hypothesis, pregnant Wistar rats were fed a control (20%) protein diet (C) or a low (8%)
protein diet during pregnancy and switched to a control diet at birth (LP). At 4 months, the
LP offspring had impaired glucose tolerance. In addition, LP offspring had decreased LXRa
expression, while hepatic expression of 11b-HSD1 and G6Pase was significantly higher.
This was concomitant with decreased binding of LXRa to the putative LXRE on 11b-Hsd1
and G6pase. Finally, we demonstrated that the acetylation of histone H3 (K9,14) surrounding
the transcriptional start site of hepatic Lxra (Nr1h3) was decreased in LP offspring, suggesting
MPR-induced epigenetic silencing of the Lxra promoter. In summary, our study demonstrates
for the first time the important role of LXRa in mediating enhanced hepatic gluconeogenic
gene expression and consequent glucose intolerance in adult MPR offspring.
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Introduction
Epidemiological evidence suggests that adverse events
in utero (e.g. placental insufficiency-induced intrauterine
growth restriction (PI-IUGR)) can permanently alter
http://joe.endocrinology-journals.org
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physiological processes leading to hypertension and
type 2 diabetes (Barker et al. 1993, Nilsson et al. 1997,
Jaquet et al. 2000, Levitt et al. 2000, Huxley et al. 2007).
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Previous animal models of maternal protein restriction
(MPR) have consistently linked asymmetric IUGR (Desai &
Hales 1997) with symptoms of type 2 diabetes long-term in
the offspring. For example, Petrik et al. (1999) demonstrated a low protein diet during pregnancy and weaning
induced a decrease in birth weight and disrupted pancreatic
b-cell proliferation in the adult offspring. Other studies
have found altered glucagon-stimulated and insulinstimulated hepatic glucose output as well as reduced
glucokinase expression and structural modifications in
the livers of low protein offspring (Ozanne et al. 1996, Burns
et al. 1997). In addition, Chamson-Reig et al. (2009) have
demonstrated that low protein offspring have impaired
glucose tolerance as early as 130 days of age in rat offspring.
Thus, the evidence strongly suggests that maternal low
protein-mediated IUGR in the rat predisposes the offspring
to impaired glucose tolerance and a type 2 diabetes-like
phenotype. However, the molecular mechanisms underlying these low protein-induced alterations in the output of
hepatic glucose are not completely understood.
The liver X receptor (LXR) is a transcription factor
belonging to the 1H subfamily of nuclear receptors. LXR
exists as two isoforms: LXRa and LXRb. LXRa is mainly
expressed in the liver, adipose tissue, macrophages and
intestines (Apfel et al. 1994, Willy et al. 1995), while LXRb
is ubiquitously expressed (Song et al. 1994). Endogenous
ligands for LXR are mainly derivatives of cholesterol
(i.e. oxysterols; Lehmann et al. 1997, Song & Liao 2000).
Consequently, LXR has principally been implicated in
regulating genes involved in the metabolism and transport of cholesterol (Lehmann et al. 1997, Venkateswaran
et al. 2000) and in enhancing the expression of lipogenic
enzymes (Repa et al. 2000). Recent studies have also
demonstrated that LXR can silence genes involved in
glucose production including phosphoenolpyruvate
kinase (PEPCK) and glucose-6-phosphatase (G6Pase),
both critical enzymes involved in the gluconeogenic
pathway (Stulnig et al. 2002a,b, Cao et al. 2003). In
addition, LXR has also been found to indirectly downregulate hepatic glucose production through inhibition
of the enzyme 11b-hydroxysteroid dehydrogenase-1
(11b-HSD1; Stulnig et al. 2002a). 11b-HSD1 reduces
inactive corticosteroids to their active form (e.g. 11dehydrocorticosterone to corticosterone in the rodent).
Since active corticosteroids are responsible for increased
glucose production, LXR-mediated inhibition of 11b-HSD1
would indirectly decrease glucose production.
Previous studies from our own laboratory have found
that MPR leads to decreases in the expression of the LXRtarget gene, Cyp7a1, the critical enzyme involved with
http://joe.endocrinology-journals.org
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cholesterol catabolism. The decrease in Cyp7a1 leads
to hypercholesterolemia in male offspring by 4 months
(Sohi et al. 2011). This was found to be due, in part, to
repressive changes in histone modifications at the LXRE
site of the Cyp7a1 promoter. Other studies in mice have
demonstrated that MPR leads to hypermethylation of
the Lxra (Nr1h3) promoter in association with decreased
Lxra mRNA in the liver tissue of embryonic day 19.5
fetuses, however the effect on posttranslational histone
modifications surrounding Lxra remains elusive (van
Straten et al. 2010). While others and we have demonstrated that MPR can lead to long-term epigenetic
alterations of LXR-target genes involved in cholesterol
and lipid homeostasis, it is not known if LXR-target genes
impairing hepatic gluconeogenesis are altered.
The aims of the present study were to examine whether
MPR alters LXRa-mediated gluconeogenesis in the liver.
Given the role of LXRa in lipid, glucose and cholesterol
homeostasis, it is an attractive candidate in elucidating the
molecular mechanisms underlying IUGR-related fetal programming. We hypothesized that decreased maternal
protein availability during gestation would impair hepatic
gluconeogenesis in the adult offspring through decreases in
LXRa and aberrant activity of its target genes (G6pase (G6pc),
Pepck (Pck1) and 11b-Hsd1 (Hsd11b1)). Using a wellestablished model of MPR in rat pregnancy, we assessed the
effects of a low protein diet in gestation on long-term glucose
handling, LXRa activity, and the expression of hepatic LXRtarget genes involved in gluconeogenesis. In the control
group, dams were fed a 20% protein diet throughout life. Low
protein dams received an 8% protein diet until birth of the
offspring, followed by a 20% protein diet during the weaning
period (until postnatal day 21). We decided to examine the
effects of restoring protein immediately after birth as
opposed to waiting until after the weaning period because
we have already demonstrated that earlier restoration of
protein promotes accelerated catch-up growth (Sohi et al.
2011). Moreover, postnatal accelerated growth of IUGR
offspring has been demonstrated to exacerbate the effects of
IUGR-related programming and reduce the lifespans of these
offspring (Ozanne & Hales 2004, Chen et al. 2009,
Tarry-Adkins et al. 2013).

Materials and methods
Animal experiments and dietary regime
All procedures were performed in accordance with the
guidelines set by the Canadian Council of Animal Care
and upon approval of the Animal Care Committee of the
Published by Bioscientifica Ltd.
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University of Western Ontario. Male and female Wistar
rats at breeding age (250 g) were purchased from Charles
River (La Salle, St-Constant, QC, Canada) and were
allowed to acclimatize to their new environment for
2 weeks. Rats were housed at room temperature on a
12 h light:12 h darkness cycle. Females were housed in
separate cages and were cohabitated with a male for
mating upon entering proestrus. Conception was
confirmed by the presence of sperm in the vaginal smear
the following day.
Dams and offspring received isocaloric diets (Bio-Serv,
Frenchtown, NJ, USA) varying in protein composition,
depending on their experimental group. Briefly, the
control offspring and dams received 20% protein throughout life. Protein-restricted dams received low protein chow
(8%) throughout gestation and then restored on a 20%
protein chow immediately after birth (herein termed ‘LP’).
All diets and water were administered ad libitum. Previous
studies by our laboratory have demonstrated that the food
intake between both offspring groups is practically
identical (Sohi et al. 2011).
At embryonic day 19, a subset of dams (three control
dams; four LP dams) was sacrificed and livers from the
fetuses were extracted. The livers were flash frozen for
further molecular analysis. The other subset of dams (four
control dams; four LP dams) delivered spontaneously. All
litters with less than ten pups were arbitrarily culled down
to 9–10 pups to ensure a consistent litter size per dam.
After their intraperitoneal glucose tolerance tests
(IPGTT) at postnatal days 120–125, all offspring were
sacrificed using a lethal dose (50 mg/kg) of Euthanyl forte
pentobarbital sodium (Bimeda-MTC, Cambridge, ON,
Canada) at postnatal day 130. This age was chosen because
previous studies have demonstrated that in other models
of protein restriction, impaired glucose tolerance was not
observed earlier than 4 months (Chamson-Reig et al.
2009). Following sacrifice, liver and blood were immediately extracted and flash frozen at K80 8C for molecular
analysis. We did not examine the female offspring in this
study to prevent confounding factors related to their
estrus cycle and hormone profile. More importantly, the
maternal low protein model has been demonstrated to
exhibit early life programming effects in a sexually
dimorphic manner, which was not the focus of this
investigation (Guan et al. 2005, Chamson-Reig et al.
2009, Sohi et al. 2011). For molecular analysis, one-totwo male pups from each of four separate dams were
arbitrarily chosen. All available male pups were used for
the IPGTT.
http://joe.endocrinology-journals.org
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Glucose tolerance tests
At postnatal days 120–125, male offspring were subject
to an IPGTT. Prior to the IPGTT, the animals were fasted
overnight for 14–16 h. Animals were awake throughout
the experiment. Blood glucose measurements were
obtained using a Bayer Breeze 2 Blood Glucose Meter
(Bayer). Fasted blood glucose levels were obtained prior
to the glucose injection. Animals then received 2 g/kg of
glucose via injection into the i.p. cavity. Blood glucose
was sampled at the tail vein at tZ0, 5, 10, 15, 30, 60 and
120 min. Area under the curve of each animal was
calculated using (GraphPad Prism Software, San Diego,
California, USA, www.grpahpad.com). IPGTTs were performed on six control males and ten LP males.

Quantitative real-time PCR for gene expression analysis
Total RNA was extracted from the medial lobe of offspring
livers at embryonic day 19 and postnatal day 130 as
previously described, using the one-step TRIzol (Invitrogen) method (Sohi et al. 2011). Total RNA was
subsequently treated with deoxyribonuclease to eliminate
contaminating DNA. Four micrograms of total RNA were
then reverse transcribed to cDNA using random primers
and Superscript II RNase H-reverse transcriptase (Invitrogen). TaqMan probes and sequences for the genes of
interest (11b-Hsd1, G6pase, Lxra, Pepck and b-actin (Actb))
and TaqMan Universal Master Mix were obtained from
Invitrogen. Quantitative analysis of mRNA expression was
measured using the Bio-Rad CFX384 Real Time System.
The cycling conditions were as follows: polymerase
activation (95 8C for 10 min) followed by 40 cycles of
denaturing (95 8C for 15 s) and annealing (60 8C for
1 min). The cycle threshold was set where the exponential
increase in amplification was equivalent between all
samples. Relative fold changes were calculated using the
comparative cycle times (Ct) method with b-actin as the
reference gene. DCt values for each probe set were
standardized to the experimental samples with the lowest
transcript abundance (highest Ct value). The relative
abundance of each primer set compared with calibrator
was determined by the formula, 2DDCt, where DDCt was the
standardized Ct value.

Tissue protein extraction and western immunoblotting
Tissue protein was extracted from the medial lobe of snapfrozen offspring livers using a lysis buffer solution (pH 7.4,
Tris–HCl 50 mM, NP-40 1%, sodium deoxycholate 0.25%,
Published by Bioscientifica Ltd.

Downloaded from Bioscientifica.com at 07/04/2022 03:40:07PM
via free access

Journal of Endocrinology

Research

T X VO

and others

NaCl 150 mM, EDTA 1 mM, NaF 50 mM, Na3VO4 1 mM
and b-glycerophosphate 25 mM). Prior to tissue homogenization, a mini protease inhibitor tablet was added to the
lysis buffer.
First, a small chunk of snap-frozen liver was added to
600 ml of RIPA buffer. The tissue was then homogenized
with the IKA T10 Basic S1 Dispersing Tool (IKA Works,
Inc., Wilmington, NC, USA) for 10–15 s at speed 6. After
letting the homogenized tissue sit on ice for 5 min, the
tissue was then sonicated. Following sonication, the tissue
was rotated at 4 8C for 5 min and then centrifuged for
15 min at 300 g and 4 8C. The supernatant was retained for
further centrifugation at 20 000 g for 20 min at 4 8C. The
final supernatant was retained for protein quantification
and western immunoblotting.
Equal concentrations of total protein were normalized
using a colorimetric BCA Protein Assay (Pierce Corp.,
Madison, WI, USA). Proteins were then fractionated in
17-well gradient polyacrylamide gels (Invitrogen) and
transferred onto PVDF membrane (Millipore, Etobicoke,
ON, Canada). Amido black and Coomassie brilliant blue
staining confirmed sufficient transfer of proteins onto the
membrane.
Immunoblots were probed using LXRa (LXR; 1:1000;
cat no. sc-13068), PEPCK (1:2000; cat no. sc-32879), G6Pasea (1:1000; cat no. sc-25840), PI3-kinase p85a (Z-8; 1:1000;
cat no. sc-423) and 11b-HSD1 (1:800; cat no. sc-20175) all
from Santa Cruz Biotechnology. In addition, p-Akt1 (Serine
473; 1:1000; cat no. ab66138), p-Akt (Threonine 308; 1:500;
cat no. 4796) and Akt (1:125; cat no. ab6076) antibodies used
to assess hepatic insulin sensitivity were purchased from
Abcam, Inc. (Cambridge, MA, USA). In addition, we also
assessed insulin sensitivity by using antibodies against pIRS-1 (Serine 302; 1:500; cat no. 2384), p-IRS-1 (Serine 1101;
1:500; cat no. 2385) and IRS-1 (1:500; cat no. 2382) all
purchased from Cell Signaling (Danvers, MA, USA). Monoclonal HRP conjugated b-actin (1:50 000; cat no. A3854;
Sigma–Aldrich) diluted in 5% milk–TBS–Tween-20 (0.1%)
buffer and HRP conjugated donkey anti-rabbit IgG
(1:10 000, cat no. 711-035-152; Jackson ImmunoResearch
Laboratories, West Grove, PA, USA) diluted in 5% milk–TBS–
Tween-20 (0.1%) buffer were used as the secondary
antibodies. Finally, immunostained bands were then
visualized using an ECL detection system (Thermo Scientific, Waltham, MA, USA).

Chromatin immunoprecipitation
Chromatin was extracted from the medial lobe of offspring
livers as previously described (Sohi et al. 2011). Briefly, a
http://joe.endocrinology-journals.org
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small piece of snap-frozen liver was homogenized and
incubated with 1% formaldehyde for 10 min at room
temperature to cross-link proteins and DNA. Cross-linking
was terminated by the addition of glycine (0.125 M, final
concentration). The liver tissue was washed once with cold
PBS and placed in 500 ml of SDS lysis buffer (Millipore) with
a protease inhibitor cocktail (Roche). The lysates were
sonicated on ice to produce sheared, soluble chromatin.
The lysates were diluted 10 times with the addition of
chromatin immunoprecipitation (ChIP) dilution buffer
(Millipore) and aliquoted to 400 ml amounts. Each of the
aliquots was precleared with protein A/G Plus agarose
beads (40 ml; Millipore) at 4 8C for 30 min. The samples
were centrifuged at 20 000 g to pellet the beads, and the
supernatant containing the sheared chromatin was placed
in new tubes. The aliquots were incubated with 4 mg of
antibodies against RNA polymerase II (cat no. 05-623B;
Millipore), trimethylated histone H3 lysine 4 (K4; cat no.
ab1012; Abcam, Inc.), acetylated histone H3 lysine 9,14
(K9,14; cat no. 05-399; Millipore), trimethylated histone
H3 lysine 9 (K9; cat no. 07-442; Millipore) and ChIP-grade
LXRa (cat no. sc-13068x; Santa Cruz Biotechnology) at
4 8C overnight. Two aliquots were reserved as ‘controls’ –
one incubated without antibody and the other with
nonimmune IgG (Millipore). Protein A/G Plus agarose
beads (60 ml) were added to each tube, the mixtures
incubated for 1 h at 4 8C and the immune complexes
collected by centrifugation. The beads containing the
immunoprecipitated complexes were washed sequentially
for 5 min in wash buffer I (20 mM Tris–HCl, pH 8.1, 2 mM
EDTA, 0.1% SDS, 1% Triton X-100 and 150 mM NaCl),
wash buffer II (same as I, except containing 500 mM
NaCl), wash buffer III (10 mM Tris–HCl, pH 8.1, 1 mM
EDTA, 1% NP-40, 1% deoxycholate and 0.25 M LiCl), and
in 2! TE buffer. The beads were eluted with 250 ml elution
buffer (1% SDS, 0.1 mM NaHCO3C20 g salmon sperm
DNA (Sigma–Aldrich)) at room temperature. This was
repeated once and eluates were then combined. Crosslinking of the immunoprecipitated chromatin complexes
and ‘input controls’ (10% of the total soluble chromatin)
was reversed by heating the samples at 65 8C for 4 h.
Proteinase K (15 mg; Invitrogen) was added to each sample
in buffer (50 mM Tris–HCl, pH 8.5, 1% SDS and 10 mM
EDTA) and incubated for 1 h at 45 8C. The DNA was
purified by phenol–chloroform extraction and precipitated in EtOH overnight at 20 8C. Samples and ‘input’
controls’ were diluted in 10–100 ml TE buffer just prior to
quantitative real-time PCR (qRT-PCR).
Putative LXR-binding sites (threshold of 0.7) on the
promoters of G6pase and 11b-Hsd1 were determined using
Published by Bioscientifica Ltd.
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the MatInspector Software (Genomatix, Munich,
Germany). The MatInspector Software was used to match
the LXR consensus binding site (AGGTCA_DR4_AGGTCA; Willy et al. 1995) with putative transcription
factor binding sequences based on algorithms as described
by Cartharius et al. (2005). qRT-PCR was employed using
forward (5 0 -GGTCACTGCATGATCACAGG-3 0 ) and reverse
(5 0 -CCTTGGAATCCAGAATGCTC-3 0 ) primers that amplify
a K35 to C92 bp region encompassing the rat G6pase
LXRE site (C22 to C46 bp), and forward (5 0 -TTCGCCAAACTCTGACCTCT-3 0 ) and reverse (5 0 -ACAGGTTTGGCCTGGAT-GT-3 0 ) primers that amplify a K115 to K7 bp region
encompassing the rat 11b-Hsd1 LXRE site (K114 to K90
bp) (PE Applied Biosystems). The LXRa (gene: Nr1h3)
transcriptional start site (TSS) was found using the
Ensembl Genome Browser (http://www.ensembl.org).
Forward (5 0 -GGCTTCACTGGTTGATCCAT-3 0 ) and reverse
(5 0 -AGGGGGTTGATTCTTGAGGT-3 0 ) primers were
designed to amplify the K135 to C144 bp region
surrounding the C1 bp TSS of Lxra. Recent evidence
indicates that there is epigenetic regulation in the CG-rich
regions of the Lxra promoter around the TSS in another
rodent model of MPR (van Straten et al. 2010). Thus,
primers around the promoter were used to examine the
binding of RNA polymerase II, acetylation of histone H3
(K9,14), methylation of histone H3 (K4) and trimethylation of histone H3 (K9) at the TSS of Lxra.
The aforementioned constructed ChIP primers were
then used in conjunction with Sso-Fast EvaGreen Supermix (Bio-Rad) to perform qRT-PCR. Similar to the gene
expression assays, the relative abundance of the immunoprecipitated chromatin compared with input chromatin
was determined using the 2DDCt method.

Statistical analysis
All data are represented as a mean of an arbitrary valueG
S.E.M. IPGTT, areas under the curve, qRT-PCR (including
ChIP) and quantified western immunoblot bands were
analyzed using the unpaired Student’s t-test. All data with
a P value !0.05 were considered statistically significant.

MPR alters LXR-mediated
gluconeogenesis

218:1

89

significantly different between control and LP animals.
After administration of the glucose (2 g/kg), measured
blood glucose levels were significantly elevated (P!0.05)
in LP animals at the 10-, 15-, 30- and 60-min time points
(Fig. 1A). Blood glucose levels in the LP animals returned
to the same levels as the control animals by the 120-min
time point. At the end of the experiment, both control and
LP animals had similar blood glucose levels. The area
under the curve for the LP animals was increased by 32.8%
(P!0.05) compared with the control animals (Fig. 1B),
further indicating impaired glucose tolerance at 4 months
of age. Although we did not perform insulin tolerance
tests, hepatic insulin sensitivity was assessed through
western immunoblot detection of phosphorylated-Akt1
(S473 and T308), the p85 subunit of phosphoinositide
3-kinase (p85), and the phosphorylated IRS-1 (S302 and
S1101), all markers of insulin sensitivity (Guo et al. 2009,

A

**

30
Blood glucose (mmol/l)

T X VO

Control

*

LP

*
20

10

0

20

40

60

80

100

120

Time (min)

B
Area under the curve
(arbitary values)

Journal of Endocrinology

Research

3000

*

2000

1000

0
Control

LP

Treatment group

Results
MPR leads to impaired glucose tolerance at
4 months of age in male offspring
At 4 months of age, all of the male offspring underwent an
IPGTT to assess fasted glucose tolerance after an administered glucose load. Resting levels of glucose were not
http://joe.endocrinology-journals.org
DOI: 10.1530/JOE-13-0055
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Figure 1
(A) Intraperitoneal GTT (2 g/kg) administered to fasted male offspring at
4 months of age. Control and LP animals were analyzed together at each
time point (tZ0, 5, 10, 15, 30, 60 and 120 min) using the Student’s unpaired
t-test. (B) Area under the curve of control and LP animals. Area under
the curve was calculated using GraphPad Prism Software. (Control nZ6,
LP nZ10). Results are expressed as the meanGS.E.M. *Statistically
significant (P!0.05).
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Valverde & Gonzalez-Rodriguez 2011). Protein expression
of these proteins was unchanged between control and LP
animals, suggesting no difference in insulin sensitivity
between the experimental groups at 4 months of age
(Supplementary Figure 1A and B, see section on supplementary data given at the end of this article).

Given the LP animals exhibited glucose intolerance at
4 months of age, we subsequently investigated the
expression of hepatic LXRa and its target genes involved
in gluconeogenesis. To determine differences in in vivo
hepatic mRNA levels of Lxra, G6pase, 11b-Hsd1 and Pepck
at 4 months of age in the male offspring, qRT-PCR was
employed with TaqMan probes for each gene. Lxra mRNA
was significantly decreased by 45% (P!0.05) in the LP
offspring, while Pepck mRNA was unchanged between
groups (Fig. 2). Hepatic G6pase and 11b-Hsd1 mRNA were
significantly increased (P!0.05, 1.6-fold) in the LP offspring (Fig. 2).

To assess the effect of a maternal low protein diet on the
protein levels of LXRa and LXR-target genes in 4-monthold offspring, we performed western immunoblotting to
determine if there would be similar trends to what was
observed in the steady-state mRNA levels. At 4 months of
age, LXRa protein expression was decreased by 40%
(P!0.05), while both G6PASE and 11b-HSD1 protein
levels were increased (P!0.05, 1.5- and 1.6-fold respectively) in the LP animals compared with the control
animals (Fig. 3). PEPCK protein expression was not
different between the two groups.

LXRa binding to the LXRE on the promoters of G6pase
and 11b-Hsd1 is decreased by 4 months of age in
the LP offspring
To investigate whether the changes in the expression of
G6Pase and 11b-HSD1 between the control and LP
offspring were due to the decreased binding of LXRa to
the promoters of G6pase and 11b-Hsd1, we employed ChIP
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Figure 2
The effect of LP on in vivo hepatic levels of (A) Lxra mRNA, (B) Pepck mRNA,
(C) G6pase mRNA and (D) 11b-Hsd1 mRNA in control and LP offspring at
4 months of age. Data were quantified from qRT-PCR (TaqMan) and the
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The levels of hepatic LXRa protein are decreased,
concomitant with an increase in G6PASE and 11b-HSD1
protein levels in LP animals by 4 months of age
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decreased, concomitant with an increase in G6pase and
11b-Hsd1 mRNA in LP animals by 4 months of age
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DDCt method. Data are represented as arbitrary values and were
analyzed using the Student’s unpaired t-test. Results are expressed as the
meanGS.E.M. *Statistically significant. nZ4–6 per experimental group.

Published by Bioscientifica Ltd.

Downloaded from Bioscientifica.com at 07/04/2022 03:40:07PM
via free access

Research

T X VO

and others

MPR alters LXR-mediated
gluconeogenesis

LXRα

Hepatic LXRα: β-actin
protein expression
(arbitrary values)

1.5

1.0

*

0.5

0.0
Control

3
2
1
0

LP

Control

LP

Experimental group
D

G6PASE

1.5

*

1.0

0.5

0.0
Control

LP

Experimental group

Hepatic 11β-HSD1: β-actin
protein expression
(arbitrary values)

Hepatic G6PASE: β-actin
protein expression
(arbitrary values)

C

PEPCK

4

Experimental group

Journal of Endocrinology

91

B

Hepatic PEPCK: β-actin
protein expression
(arbitrary values)

A

218:1

11β-HSD1

0.8

*

0.6
0.4
0.2
0.0
Control

LP

Experimental group

Figure 3
The effect of LP on the in vivo hepatic levels of (A) LXRa protein (50 kDa),
(B) PEPCK protein (62 kDa), (C) G6PASE protein (36 kDa) and (D) 11b-HSD1
(34 kDa) protein in control and LP offspring at 4 months of age. Data were
obtained from western immunoblotting experiments. Immunoblots were

quantified using densitometry and normalized to b-ACTIN (42 kDa)
protein expression. Data are represented as arbitrary values. Results are
expressed as the meanGS.E.M. *Statistically significant. nZ4–6 per
experimental group.

to immunoprecipitate LXRa. After using MatInspector
(Genomatix) to find putative LXREs on the promoters of
G6pase and 11b-Hsd1, qRT-PCR was employed to examine
LXRa binding at these putative LXRE sites. By 4 months of
age, the LP animals exhibited a marked decrease in the
binding of LXRa to the promoter of 11b-Hsd1 (45%
decrease) and G6pase (50% decrease) compared with the
control animals (P!0.05) (Fig. 4). The nonspecific binding
of IgG was tested and found to be minimal (Ct value O34,
data not shown).

in the acetylation of histone H3 (K9,14), a hallmark of
chromatin silencing, near the TSS of Lxra (Fig. 5C). While
not significant, we also found a decreasing trend in the
recruitment of RNA polymerase II binding and histone H3
trimethylation (K4) at the same site (Fig. 5A and B). Again,
the nonspecific binding of IgG was tested and found to
be minimal (Ct value O34, data not shown). These results,
in combination, support the notion that Lxra is transcriptionally and epigenetically silenced long-term in our
MPR model of IUGR.

Acetylation of lysine residues 9 and 14 on histone H3 is
decreased surrounding the TSS of Lxra in LP offspring by
4 months of age

The steady-state levels of hepatic Lxra mRNA are
unchanged between control and LP offspring
concomitant with a decrease in G6Pase and
11b-Hsd1 mRNA in LP animals at embryonic day 19

We further employed ChIP to examine the epigenetic
regulation of Lxra at its TSS. By immunoprecipitating
chromatin with antibodies specific to RNA polymerase II,
trimethylated histone H3 (K9), acetylated histone H3
(K9,14) and trimethylated histone H3 (K4) we were able
to examine the transcriptional and epigenetic regulation
of Lxra in our model of MPR. Using primers specific to the
K144 to C134 region of the Lxra gene promoter and
qRT-PCR, we found a significant 45% reduction (P!0.05)
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To assess the direct effects of the LP diet on Lxra and
LXR-target gene expression during gestation and prior to
birth, we analyzed the livers of fetuses sacrificed at
embryonic day 19. qRT-PCR was employed with TaqMan
probes for (Lxra, G6pase and 11b-HSD1 (Pepck could not be
detected in our embryonic liver tissue). At embryonic day
19, there were no differences in Lxra mRNA expression between the control and LP animals. However,
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Figure 4
The effect of LP on the in vivo hepatic binding of LXRa to the promoters of
(A) G6pase (C22 to C46 bp) and (B) 11b-Hsd1 (K114 to K90 bp) in
control and LP offspring at 4 months of age. Putative LXRE sites were
determined using the MatInspector Software from Genomatix. Livers were
immunoprecipitated with antibodies specific to LXRa. Quantification was
performed using qRT-PCR (Sso-Fast EvaGreen) with primers specific to
the proposed LXRE sites. The relative amount of immunoprecipitated
genomic DNA was normalized to total genomic DNA. Data are represented
as arbitrary values using the DDCt method. Results are expressed as the
meanGS.E.M. *Statistically significant. nZ4–6 per experimental group.
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both G6pase and 11b-Hsd1 mRNA expression were
decreased in LP offspring compared with control offspring
(P!0.05; Fig. 6).

Discussion
Our present study demonstrates that male offspring of LP
dams exhibit increased expression of hepatic gluconeogenic genes due to aberrant expression of hepatic LXRa.
This is of great interest considering that previous studies
have indicated that MPR leads to glucose dysregulation
(Ozanne et al. 1996, Burns et al. 1997, Chamson-Reig et al.
2009). We present evidence for the first time that
suppressed expression of LXRa may mediate the enhanced
transcription of the gluconeogenic genes G6pase and
11b-Hsd1 due to its decreased binding on these promoters,
ultimately removing its ability to suppress hepatic
gluconeogenesis (Stulnig et al. 2002a, Cao et al. 2003,
Laffitte et al. 2003, Mitro et al. 2007).
Given placental insufficiency in humans can produce
protein deficiency in the fetus (Crosby 1991), this LP
model shares features in common with PI-IUGR (Ross &
Beall 2008). Previous studies done in our laboratory with
the same cohort of animals have already demonstrated
that LP offspring exhibit a 15% lower fetal to placental
weight ratio and a 40% decreased fetal liver to body weight
ratio at embryonic day 19 (Sohi et al. 2011). While
switching the low protein offspring to a control diet at
weaning led to glucose intolerance (Chamson-Reig et al.
2009), little is known about how catch-up growth due to
early restoration of protein (Sohi et al. 2011) influences
their hepatic glucose handling by adulthood. In our LP
model, after switching to a control (20% protein) diet at
birth, the animals exhibited full catch-up growth by 3
weeks of age (Sohi et al. 2011). Moreover, by 4 months,
these offspring exhibited impaired glucose tolerance with
no evidence of hepatic insulin insensitivity. Given that
glucose intolerance precedes insulin resistance, it is likely
that these MPR offspring will develop insulin resistance at
a later time point. Interestingly, the impaired glucose
tolerance was similar, not worse, to low protein offspring
at 4 months whereby their diet was switched to 20% at
weaning (Chamson-Reig et al. 2009). Collectively, both
studies further support of the main tenets of the Thrifty
Phenotype hypothesis (Hales & Barker 1992).
We previously found that LXRa expression and
binding could be influenced by maternal diet by 3 weeks
of age in the offspring (Sohi et al. 2011), but the expression
of LXRa at 4 months was unknown. In this study we
demonstrated that in LP offspring, hepatic Lxra mRNA and
Published by Bioscientifica Ltd.
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Figure 5
The effect of LP on the in vivo transcriptional and epigenetic regulation of
the Lxra TSS (K135 to C144 bp) at 4 months of age. (A) Binding of RNA
polymerase II to the Lxra TSS, (B) trimethylation of histone H3 lysine 4,
(C) acetylation of histone H3 lysine 9 and 14 and (D) trimethylation of
histone H3 lysine 9. Primers were designed based on sequencing from
Ensembl. Livers were immunoprecipitated with antibodies specific to RNA
polymerase II, trimethyled histone H3 (K4), acetylated histone H3 (K9,14),

and trimethylated histone H3 (K9). Quantification was performed using
qRT-PCR (Sso-Fast EvaGreen) with primers specific to the proposed LXR
element sites. The relative amount of immunoprecipitated genomic DNA
was normalized to total genomic DNA. Data are represented as arbitrary
values using the DDCt method. Results are expressed as the meanGS.E.M.
*Statistically significant. nZ4–6 per experimental group.

protein were decreased at 4 months of age compared with
control offspring. Given aberrant LXRa expression and
activity can alter the expression of genes involved in
hepatic gluconeogenesis (e.g. Pepck, G6pase and 11b-Hsd1;
Stulnig et al. 2002a,b, Cao et al. 2003, Laffitte et al. 2003),
we next examined whether the protein expression of these
LXR-target genes was altered in LP offspring. At 4 months,
we found increases in the steady-state mRNA and protein
levels of G6PASE in LP male rats. This is of great interest
considering that this LXR-target gene is responsible for the
final catalytic step of gluconeogenesis, the conversion of
glucose-6-phosphate to glucose. Moreover, overproduction of G6Pase does not necessarily lead to increases in
fasting glucose levels, which we also observed, but it does
lead to an enhanced glucose response (e.g. a greater area
under the curve during GTT; Trinh et al. 1998). To directly

implicate whether alterations in LXRa expression influenced the binding of LXRa to the promoter of G6pase, we
then employed ChIP to examine the in vivo binding of
LXRa to its putative LXRE on the promoter of G6pase. At
4 months of age, we observed a decrease in the binding
of LXRa to the LXRE site (C22 to C46) of the G6pase
promoter. These data suggests that the increase of G6pase
expression seen in protein restricted offspring is at least
partly due to the decreased binding of LXRa to the
putative G6pase promoter. Overexpression of PEPCK has
also been demonstrated to impair glucose tolerance and
leads to noninsulin-dependent diabetes (Valera et al.
1994), however we did not find any significant alterations
in Pepck mRNA or protein. This is in contrast to other
studies whereby hepatic PEPCK activity increased in
3-week-old and 11-month-old offspring fed a low protein
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Figure 6
The effect of LP on in vivo hepatic levels of (A) Lxra mRNA, (B) G6pase
mRNA and (C) 11b-Hsd1 mRNA in control and LP offspring at embryonic day
19. Data were quantified from qRT-PCR (TaqMan) and the DDCt method.
Data are represented as arbitrary values and were analyzed using Student’s
unpaired t-test. Results are expressed as the meanGS.E.M. *Statistically
significant. nZ4–6 per experimental group.

diet during gestation (Desai et al. 1995), and low protein
offspring fed a high sucrose diet (500 g/kg) postpartum
(Burdge et al. 2007). The difference in the former study
may be due to the fact that the offspring were crossfostered to dams not subjected to a low protein diet,
potentially leading to even greater catch-up growth.
11b-HSD1 may also play a role in impairing glucose
homeostasis in our LP model. Our study demonstrated an
http://joe.endocrinology-journals.org
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increase in 11b-Hsd1 mRNA along with elevated 11b-HSD1
protein levels in the LP offspring. Interestingly, while
previous nutrient restriction models have demonstrated
no change in 11b-HSD1 expression in the adipose tissue
of adult rat offspring (Dutriez-Casteloot et al. 2008), its
expression in the liver was not examined. Similar to
G6pase, we proposed that a decrease in LXRa expression
and binding would lead to the loss of inhibitory action on
the 11b-Hsd1 promoter and a subsequent increase in
11b-Hsd1 gene expression. Our ChIP experiments
confirmed our speculation by demonstrating a decrease
in LXRa binding to the putative LXRE (K114 to K90) on
11b-Hsd1. With increased expression of 11b-HSD1, it is
conceivable that there would be enhanced conversion of
inactive glucocorticoids to active glucocorticoids. Since
glucocorticoids have stimulatory effects on the expression
of gluconeogenic genes such as G6pase and Pepck (Sasaki
et al. 1984, Lange et al. 1994, Lin et al. 1998), the sustained
overproduction of glucocorticoids would lead to an
augmented glucose response, as observed in the IPGTTs.
Collectively, it is likely that the overproduction of G6Pase
may not only occur due to the direct actions of LXRa, but
also indirectly through enhanced 11b-HSD1 expression.
Previous studies strongly suggest the role of epigenetics in mediating the effects of fetal programming longterm into adulthood (Rees et al. 2000, Lillycrop et al. 2005,
Burdge et al. 2007, Park et al. 2008, van Straten et al. 2010).
By 4 months of age, we demonstrated that LP males
exhibited significantly decreased acetylation of histone H3
(K9,14) associated with trends of decreased RNA polymerase II recruitment and decreased methylation of
histone H3 (K4) surrounding the promoter of Lxra.
Considering acetylation of histone H3 (K9,14) and
methylation of histone H3 (K4) are both known to be
hallmarks of chromatin opening (Jenuwein & Allis 2001,
Santos-Rosa et al. 2002, Yan & Boyd 2006), our findings
suggest that the Lxra TSS is silenced through epigenetic
mechanisms by adulthood. These findings are congruent
with the decreased levels of Lxra mRNA and protein
expression observed. We previously demonstrated that
MPR leads to long-term decreases in histone H3 acetylation
(K9,14) surrounding the promoter of the LXR-target gene
Cyp7a1 resulting in hypercholesterolemia in these offspring (Sohi et al. 2011). To address whether the low protein
diet itself directly alters hepatic LXRa and LXR-target genes
in vivo, we measured their fetal expression (embryonic day
19) during the low protein insult. Interestingly, the low
protein diet impaired these hepatic genes involved in
gluconeogenesis without changes to LXRa expression. This
suggests that the augmented expression of LXRa, G6Pase
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and 11b-HSD1 observed in adulthood is more likely due to
the indirect actions of the low protein diet, namely, a
protein mismatch in postnatal life associated with rapid
catch-up growth.
In view of the fact that LXRa suppresses glucose
production, it may be a suitable target as a therapeutic
intervention to prevent glucose intolerance. Animal
studies have widely demonstrated that the administration
of LXR agonists (e.g. GW3965 and T0901317) leads to
improved glucose tolerance (Cao et al. 2003, Laffitte et al.
2003). Given that during the newborn period in the rat
there is a high rate of replication, neogenesis and
apoptosis leading to extensive liver remodeling (Cascio
& Zaret 1991), this period represents a critical, but
opportune window for therapy designed to improve
hepatic growth and function long-term. For example, it
has been demonstrated in IUGR rats derived from uterine
artery-ligated dams that neonatal administration of
Exendin-4 (a GLP-1 analog) prevented the development
of hepatic oxidative stress and insulin resistance (Raab et
al. 2009). Therefore it is plausible that LXRa agonists,
administered in neonatal life, a period of liver plasticity,
may prevent the development of glucose intolerance longterm through activation of hepatic LXRa. While LXR
agonists appear promising, the negative effects of LXRa
activation must also be considered, given that it can
activate lipogenesis through increased expression of fatty
acid synthase, acetyl-CoA carboxylase and the master lipid
regulator, sterol regulatory element binding protein-1c
(Steffensen & Gustafsson 2004).
In summary, our study demonstrates for the first time
the role of LXRa in mediating the transcriptional
regulation of hepatic gluconeogenic genes in our rat LP
model. In these offspring, decreased expression of hepatic
LXRa reduced the transcriptional inhibition of hepatic
G6Pase and 11b-HSD1. This increased expression of
G6Pase and 11b-HSD1 in LP offspring would contribute,
in part, to the aberrant glucose handling observed in these
animals. Given the role of hepatic LXRa in reducing
glucose production, it serves as a possible therapeutic
target of intervention due to its anti-diabetic properties.
Further studies will be necessary to find a suitable balance
between anti-diabetic and lipogenic actions of LXRa
before it could be considered as an ideal candidate for
preventing glucose intolerance in IUGR offspring.
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